MedPath

Trying to improve the compliance to colorectal cancer screening: type of test provider (GP versus hospital) and type of faecal occult blood test (Guaiac versus immunochemical)

Completed
Conditions
Colorectal cancer
Cancer
Registration Number
ISRCTN83029072
Lead Sponsor
Agency for Public Health, Lazio Region, Italy (Agenzia di Sanita Pubblica della Regione Lazio)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
7320
Inclusion Criteria

We selected 13 hospitals, out of 20 to participate in the screening programme, in order to represent all types of gastroenterology units (5 university hospitals, 2 large research hospitals, 6 local hospitals) and all geographic areas (7 in the metropolitan area of Rome, 2 in the outskirts of Rome, 4 in towns and small cities of the province). We included in a survey about screening attitudes all the GPs with an office in the 13 selected hospital districts. During the survey, all the GPs were asked to participate in a trial to evaluate the best strategies to enhance the compliance to CRCS. The conditions for eligibility of the GPs were: more than 100 people aged 50?74 in the practice population; a personal computer in the office; and consent to participate.

For each of the 13 districts we sampled 10 eligible GPs. The sampled GPs, primary sampling units, were randomised as follows: for each district, five to the immunochemical test and five to the Guaiac test. We sampled 2/10 of the target practice population for each GP; 1/10 of the population was randomised to the GP arm and 1/10 to the hospital arm.

Exclusion Criteria

We analysed the lists of randomised patients: the second member of a pair with the same telephone number was rejected and substituted, if assigned to a different arm.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Compliance to screening: (number of returned faeces samples)/(total number of invited subjects)
Secondary Outcome Measures
NameTimeMethod
Positivity rate; variability of the positivity rate; rate of inadequate samples; positive predictive value.
© Copyright 2025. All Rights Reserved by MedPath